Bkmk Hospital

KecskemĂŠt 6000

0 studies enrolling now · 4 studies all time

What they study most

Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Non Small Cell Lung Cancer, Solid Tumors

Studies at this site

• GEN1046 Safety Trial in Patients With Malignant Solid Tumors — Running, not enrolling
• Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) — Running, not enrolling
• Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations — Running, not enrolling
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer — Running, not enrolling